Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

My connections

Dayne Beccano-Kelly

Career Development Fellow in Neurobiology

Research Interests

The aim of my project is to obtain information which will contribute to the understanding of Parkinson’s disease (PD) progression.

My research involves the study of neurones derived from induced pluripotent stem cells (iPSCs).  This novel technique allows the generation of neurones from skin biopsies generously donated by patients of the OPDC Discovery Cohort.  The nature of the technique means the neurones produced have the same genetic background as the patient, including any information that may have contributed to their disorder.

I use a combination of electrophysiological, molecular biological and optogenetic techniques, in order to elucidate the synaptic and cellular phenotypes of these human PD neurones.

We believe that the comparison of these phenotypes with neurones derived from healthy patients will allow us to understand the pathogenic pathway occurring in PD and, ultimately help us to develop novel therapeutics and change clinical practice.



I graduated from the University of Leeds in 2006 with a BSc (Hons) in Biochemistry (with Industry). This included an educational/professional placement at the Mayo clinic in Jacksonville, Florida where I worked on Steele-Richardson-Olszewski syndrome (or Progressive Supranuclear Palsy; PSP) under the direction of Dr. Dennis Dickson.

I went on to obtain a Medical Research Council PhD (with Dr. Hugh Pearson and Prof. Chris Peers) investigating the relationship between stroke and Alzheimer’s disease (AD) which I completed in 2010. Specifically my project looked at the effect hypoxia had on the production of the AD related peptide amyloid β, and the subsequent pathophysiological effects on neurones.

I subsequently went on to investigate the potential neuro-protective effects of the feeding hormone leptin in AD as a postdoctoral researcher at the University of Dundee, Scotland. After this, I began work as a senior post-doctoral fellow at the University of British Columbia (Canada) Centre for Applied Neurogenetics (CAN) with Prof. Matthew Farrer and Ass. Prof. Austen Milnerwood. Here I worked on the longitudinal characterisation of genetically faithful parkinsonian models in an attempt to isolate correlates of early synaptic dysfunction and disease.

I joined Richard Wade-Martins’ group in 2015 as a Career Development Fellow in order to study “Parkinson’s disease in a dish” using human iPSCs.  Using this model, we intend to characterise the ontology of PD and identify novel therapeutics.

False False

Key Publications


Recent Publications

5 View 4 more »